The U.S. House of Representatives on Wednesday approved a bipartisan pair of psychedelics research amendments, as well as another measure requiring a military study into marijuana-related enforcement discrimination in the armed services.
The day after nine drug policy amendments to the National Defense Authorization Act (NDAA) were made in order for floor consideration by the House Rules Committee, the chamber voted favorably on an initial package of measures grouped together, including those that contains language requiring research into the therapeutic potential of substances like psilocybin, MDMA and ibogaine in addition to the cannabis proposal. Approval came on a voice vote.
House debate and votes on the remaining marijuana amendments cleared for floor action will be a multi-day process, but the three that have cleared the chamber so far as part of an en bloc group are especially unique.
Rep. Dan Crenshaw’s (R-TX) amendment would allow the secretary of defense to approve grants for research into the therapeutic potential of certain psychedelics such as MDMA, psilocybin, ibogaine and 5–MeO–DMT for active duty military members with PTSD.
Notably, an earlier, identical version of the was not made in order for the floor as part of last year’s NDAA, signaling that attitudes toward
Read full article on Marijuana Moment
